Axios · Brock E.W. Turner ·

French pharma SaaS startup Biolevate raised a €30M Series A co-led by RAISE France and Orange Ventures, taking its total funding to €36M

Biolevate, a French pharma-focused SaaS startup, raised €30 million in Series A funding, CEO Joël Belafa tells Axios Pro exclusively.

Venture Capital

In this story Biolevate Orange Ventures RAISE France

French pharma SaaS startup Biolevate raised a €30M Series A co-led by RAISE France and Orange Ventures, taking its total funding to €36M

Lead Source

Axios — French pharma SaaS startup Biolevate raised a €30M Series A co-led by RAISE France and Orange Ventures, taking its total funding to €36M ↗

How this story grew

Coverage · 0 Discussion · 0

Sep 22Sep 23

More

Tech.eu: Tech.eu

FinSMEs: FinSMEs

The SaaS News: The SaaS News

Related stories

Tech.eu: London-based AI life sciences startup Basecamp Research raised a $140M Series C led by S32, with participation from Anthropic, taking its total funding to $225M

Tech.eu: Paris-based Arlequin AI, which is developing proprietary models based on topological neural networks, raised a €28M Series A co-led by redalpine and OTB

Dealroom.co: Faro, which develops data models and AI tools to speed up clinical trials, raised a $37.3M Series B co-led by Merck Global Health Innovation Fund and S32

Bloomberg: Australian healthcare AI startup Heidi raised $340M, including a $100M Series C led by Blackbird at a $900M valuation, taking its total funding to $430M+

Axios: Mithrl, which integrates its proprietary biomedical world model with the R&D systems of pharmaceutical companies, raised a $20M Series A led by Obvious Ventures

Discuss with AI

ChatGPT ↗ Claude ↗

← Back to TechSnif